Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Lawrence

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Expert Opinion on Investigational Drugs|July 5, 2005
38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 24-27, 1998, San Diego, CA, USAL F Discotto, M J Pucci, L E Lawrence, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Staphylococcus aureus mutants selected by BMS-284756L F Discotto, L E Lawrence, K L Denbleyker, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Selection and genetic characterization of Streptococcus pneumoniae mutants resistant to the des-F(6) quinolone BMS-284756S Hartman-Neumann, K DenBleyker, L A Pelosi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 27, 2002
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureusB M Ryan, C E Mazzucco, L E Lawrence, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2001
The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analoguesL E Lawrence, P Wu, L Fan, et al.
Expert Opinion on Investigational Drugs|July 1, 1997
The 97th Annual Meeting of the American Society for MicrobiologyM Frosco, M J Pucci, L Licata, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Antibacterial agents that inhibit two-component signal transduction systemsJ F Barrett, R M Goldschmidt, L E Lawrence, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Expert Opinion on Investigational Drugs|July 5, 2005
38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 24-27, 1998, San Diego, CA, USAL F Discotto, M J Pucci, L E Lawrence, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Staphylococcus aureus mutants selected by BMS-284756L F Discotto, L E Lawrence, K L Denbleyker, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Selection and genetic characterization of Streptococcus pneumoniae mutants resistant to the des-F(6) quinolone BMS-284756S Hartman-Neumann, K DenBleyker, L A Pelosi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 27, 2002
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureusB M Ryan, C E Mazzucco, L E Lawrence, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2001
The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analoguesL E Lawrence, P Wu, L Fan, et al.
Expert Opinion on Investigational Drugs|July 1, 1997
The 97th Annual Meeting of the American Society for MicrobiologyM Frosco, M J Pucci, L Licata, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1998
Antibacterial agents that inhibit two-component signal transduction systemsJ F Barrett, R M Goldschmidt, L E Lawrence, et al.
Pageof 3